| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/08/2001 | CA2383411A1 Hepatitis c virus replication inhibitors |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2383358A1 Methods and compositions of a novel serine protease inhibitor |
| 03/08/2001 | CA2383043A1 Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders |
| 03/08/2001 | CA2383002A1 Substituted .alpha.-hydroxy acid caspase inhibitors and the use thereof |
| 03/08/2001 | CA2382989A1 Materials and methods for inhibition of ige production |
| 03/08/2001 | CA2382961A1 Zymogen activation system |
| 03/08/2001 | CA2382953A1 Dna encoding the human serine protease c-e |
| 03/08/2001 | CA2382952A1 Induction of programmed cell death by n5 gene |
| 03/08/2001 | CA2382889A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | CA2382835A1 Use of amino acids for making medicines for treating to insulin-resistance |
| 03/08/2001 | CA2382622A1 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | CA2382611A1 Compositions for stimulating cytokine secretion and inducing an immune response |
| 03/08/2001 | CA2382570A1 Treatment of allergic rhinitis |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2382473A1 Treatment of conjunctivitis |
| 03/08/2001 | CA2382303A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | CA2382100A1 Dosages for treatment with anti-erbb2 antibodies |
| 03/08/2001 | CA2382030A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | CA2381713A1 Methods and compositions for reducing serum phosphate levels |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2380760A1 New interferon beta-like molecules |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/07/2001 | EP1081226A1 Apoptin-associating protein |
| 03/07/2001 | EP1081159A1 Purified human activin and process for producing the same |
| 03/07/2001 | EP1081148A2 Enantiomerically pure beta-D-dioxolane-nucleosides |
| 03/07/2001 | EP1080720A1 Fat emulsions for inhalational administration |
| 03/07/2001 | EP1080718A1 Composition for sustained release of human growth hormone |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080203A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
| 03/07/2001 | EP1080202A2 Convection-enhanced delivery of aav vectors |
| 03/07/2001 | EP1080200A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 03/07/2001 | EP1080198A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 03/07/2001 | EP1080195A1 Endometriosis-associated gene |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080193A2 Multivalent t cell receptor complexes |
| 03/07/2001 | EP1080192A2 Antisense oligonucleotides for treating proliferating cells |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080188A2 Human nucleic acid sequences of uterus myoma tissue |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080185A2 Myelin basic protein peptides and uses thereof |
| 03/07/2001 | EP1080184A1 Method for activating natural killer (nk) cells |
| 03/07/2001 | EP1080181A1 clpX OF STREPTOCOCCUS PNEUMONIAE |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080113A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080110A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 03/07/2001 | EP1080109A1 Method for purification of borrelia lipoprotein ospa |
| 03/07/2001 | EP1080107A2 Novel (poly)peptides which represent the epitopes of the human herpes virus type 8 |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080105A1 Phenylalanine derivatives having vla-4 antagonistic activity |
| 03/07/2001 | EP1080104A1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 03/07/2001 | EP1080103A1 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 03/07/2001 | EP1080100A1 Cytosine deaminase gene |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1079875A2 Method and compositions for treatment of cancers |
| 03/07/2001 | EP1079866A2 Methods of inhibiting clot formation |
| 03/07/2001 | EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 03/07/2001 | EP1079859A1 Bifunctional molecules and therapies based thereon |
| 03/07/2001 | EP1079856A1 Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 03/07/2001 | EP1079855A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA) |
| 03/07/2001 | EP1079854A1 Compositions and methods of modulating an immune response to an antigen |
| 03/07/2001 | EP1079853A1 Methods and means for preventing or treating inflammation or pruritis |
| 03/07/2001 | EP1079852A1 Composition based on pentoxifylline and anticytokin |
| 03/07/2001 | EP1079851A1 Use of anti-prolactin agents to treat proliferative conditions |
| 03/07/2001 | EP1079850A1 Compound delivery using rapidly dissolving collagen film |
| 03/07/2001 | EP1079849A2 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079847A2 Osteoporosis treatment |
| 03/07/2001 | EP1079846A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 03/07/2001 | EP1079844A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1 |
| 03/07/2001 | EP1079843A2 USE OF g(a)1 g(b) INTEGRIN RECEPTOR INHIBITORS AND TGF- g(b)1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 03/07/2001 | EP1079821A1 Protease inhibitors |
| 03/07/2001 | EP1079818A1 Novel compositions |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079811A1 Biodegradable sustained-release alginate gels |
| 03/07/2001 | EP1079808A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/07/2001 | EP1079805A1 Pharmaceutical composition comprising factor viii and neutral liposomes |
| 03/07/2001 | EP1079803A2 Protein formulations |
| 03/07/2001 | EP1079801A1 A pharmaceutical formulation for nasal administration |
| 03/07/2001 | EP1079792A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| 03/07/2001 | EP1079791A2 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 03/07/2001 | EP0918874B1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 03/07/2001 | EP0641325B1 Retroviral protease inhibitors |
| 03/07/2001 | EP0620736B1 Use of leukemia inhibiting factor (lif) for the treatment of tumours and sarcomas |
| 03/07/2001 | EP0587636B1 Fish vaccine for aeromonas salmonicida infection |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/07/2001 | CN1286727A Neisserial antigens |
| 03/07/2001 | CN1286726A Histamine and serotonin binding molecules |
| 03/07/2001 | CN1286698A Human angiotonin II/vasopressin receptor like gene |
| 03/07/2001 | CN1286697A NPCAHH01: human transmembrane protein E3-16 gene |
| 03/07/2001 | CN1286696A Liposomes comprising peptide antigens derived from X protein of hepatitis B virus |
| 03/07/2001 | CN1286695A Process for preparation of N2-(1 (s)-carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| 03/07/2001 | CN1286264A Action of proinsulin associated peptide on dopamine transporter and its application in treating correlative diseases |
| 03/07/2001 | CN1286263A Human Rab gene and polypeptide coded with it |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062907C Method for preparation of antibody materials |
| 03/06/2001 | US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors |
| 03/06/2001 | US6197937 Antibody which preferentially binds mammalian binding protein; for the treatment of atherosclerosis |
| 03/06/2001 | US6197934 Compound delivery using rapidly dissolving collagen film |